List I | List II | ||
A | Phase‐I | I | Post marketing surveillance |
B | Phase‐0 | II | Micro dosing |
C | Phase‐3 | III | First in human dose |
D | Phase‐4 | IV | Multicentric trials |
Choose the correct answer from the options given below:
Match the following:
(P) Schedule H
(Q) Schedule G
(R) Schedule P
(S) Schedule F2
Descriptions:
(I) Life period of drugs
(II) Drugs used under RMP
(III) List of Prescription Drugs
(IV) Standards for surgical dressing